Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALADIN: ILUVIEN Safety Study
NCT02424019Phase 4Completed
- Sponsor
- Alimera Sciences
- Start
- May 2015
- Primary completion
- Jul 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluocinolone acetonide intravitreal implant in diabetic macular edema (DME), sponsored by Alimera Sciences. Started May 2015; status: completed.
02
Drugs
fluocinolone acetonide intravitreal implant
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02424019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424019.